G6PD and malaria: Overall, the newly identified polymorphisms explain an additional nominal 4.3% of the variation in risk of severe malaria over and above the combined 7.4% for HbAS (6.3%), ABO blood group (0.2%), α-thalassemia (0.3%), and G6PD (0.5%).